Purpose of review Insulin resistance (IR) is recognized to play an important role in the
pathogenesis of dyslipidemia. This review summarizes the complex interplay between IR …

Insulin resistance (IR) is a well-established risk factor for metabolic disease. The ratio of
triglycerides to high-density lipoprotein cholesterol (TG: HDL-C) is a surrogate marker of IR …

Abstract Background: Type 2 diabetes (T2D) represents just the tip of the iceberg of the
complex metabolic alterations associated with obesity and other clinical conditions …

Childhood obesity represents a worldwide concern as many countries have reported an
increase in its incidence, with possible cardiovascular long-term implications. The …

Background Insulin resistance (IR) has been confirmed that getting involved in the
pathophysiological process of cardiovascular diseases (CVD). Recently, increasing …

Identification and quantification of insulin resistance require specific blood test which is
complex, time-consuming, and much more invasive, making it difficult to track the changes …

Background Insulin resistance predisposes to cardiometabolic disorders, which are
commonly comorbid with schizophrenia and are key contributors to the significant excess …

Background: Homeostasis model assessment for insulin resistance (HOMA-IR) is widely
used as a marker of insulin resistance in adults and has also been validated in children and …

Metabolic syndrome (MetS) is an important predictor of cardiovascular diseases in
adulthood. This study aims to examine the clinical utility of triglyceride to high‐density …

Objectives Metabolic syndrome (MS) is a fatal endocrinopathy that begins with insulin
resistance (IR) and causes abdominal obesity, glucose intolerance, or systemic disorders …